custom synthesis

Vitamin D2,D3 derivatives
Vitamin D4,97.0%-103.0%
Vitamin D4
COA.pdf
MSDS.pdf
511-28-4
 
Patent Disclaimer
 
Vitamin D derivatives by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available,or under development.

 

Custom Synthesis
Custom Synthesis range
Acridine series
Phenylpropionic acid series
Phenylbutyric acid series
Benzoic alcohol series
Benzaldehyde series
Benzoic acid series
Pyridine series
Pyrroline series
Pyrrolidine series
Furan series
Norbornylene series
Adamantane series
Quinoline series
Piperidine series
Piperazine series
Vitamin D derivatives
Custom Synthesis Quantity
10mg to 100kg
Each of custom synthesis chemical will be tested by H1-NMR/MS/UV/HPLC etc and the specturm will be sent for your approval proir to shippment..Following are the examples of H1-NMR test:
Analytical methods
H1-NMR,C13-NMR;H-H COSY,H-H NOESY,C-H HSQC,C-H HMBC;GC/ GCMS;HPLC/ LCMS;UV;FTIR;CHNS
   
Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
the buyer assumes responsibility of all patent considerations in the use of
Lano ’s Pharmaceutical Co.,Ltd product(s).
PD4
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.